Indian Researchers Develop Low-Cost Biosensor For Early Heart Attack Detection

 



Researchers have developed a flexible and economical biosensor capable of rapidly detecting myoglobin, a critical cardiac biomarker linked to the early stages of a heart attack. The innovation is expected to significantly improve early diagnosis, particularly in resource-limited healthcare settings, by enabling faster and more accessible cardiac screening.

Indo-Australian Research Collaboration

The biosensor has been developed by doctoral researcher Mohsina Afrooz through a joint programme between Birla Institute of Technology and Science Pilani Hyderabad and RMIT University. The collaborative research brings together expertise in materials science, biosensing, and biomedical engineering, strengthening Indo-Australian cooperation in advanced healthcare technologies.

Graphene-Based Myoglobin Detection

The newly developed sensor is graphene-based and detects myoglobin, a protein released into the bloodstream soon after cardiac muscle injury. Early identification of myoglobin is clinically important, as it allows physicians to diagnose cardiac events much earlier than many conventional diagnostic methods. Rapid detection can be crucial for timely medical intervention and improved patient outcomes.

Affordable And Portable Diagnostic Solution

Unlike traditional laboratory-based cardiac tests that are costly, time-consuming, and infrastructure-dependent, the new biosensor is lightweight, flexible, and low-cost. Its design makes it suitable for portable and point-of-care testing. An Indian patent has been filed for the technology, highlighting its potential for real-world deployment. Lead investigator Sanket Goel noted that the focus is on translating advanced sensing technology into affordable cardiac diagnostics.

Potential Impact In Rural And Emergency Care

The technology is expected to be particularly useful in rural hospitals, emergency care units, and low-resource health facilities where advanced diagnostic equipment is scarce. According to the researchers, the aim is to make heart attack detection faster, simpler, and scalable. The findings have been published in the international journal “IEEE Sensors Letters”, underscoring the scientific credibility and translational promise of the research.

#Biosensor
#BiosensorTechnology
#BiomedicalSensors
#ElectrochemicalSensors
#OpticalBiosensors
#Nanobiosensors
#Biosensing
#PointOfCareDiagnostics
#LabOnAChip
#BioAnalyticalSystems


World Cell Biologist Awards: 

Website Link : cellbiologist.org 

Follow Us On : 
Tumblr ; tumblr.ccom/

Comments

Post a Comment

Popular posts from this blog

Uttrakhand Forest Department Establishes Mahabharata Vatika

Image
  The Uttarakhand Forest Department has established two gardens in Haldwani, showcasing plant species referenced in ancient Indian epics. These gardens, named Ramayana Vatika and Mahabharata Vatika, aim to highlight the ecological wisdom embedded in these texts. Mahabharata Vatika Overview Mahabharata Vatika spans one acre and features 37 plant species mentioned in the epic. Chief Conservator of Forests Sanjeev Chaturvedi emphasised the research behind selecting these species. The garden features important plant species such as: Ecological Significance The garden puts stress on the importance of forests as depicted in the Mahabharata. It references the Vana Parva, which discusses tree planting and wildlife conservation . The epic highlights the mutual dependence of tigers and forests, a concept vital to contemporary conservation efforts. Cultural Connections Chaturvedi brought into light that the Mahabharata teaches the spiritual significance of planting trees. He mentioned Bhish...
Read more

CAR T-Cell Therapy for Cancer

Image
  India has recently made strides in cancer treatment with the introduction of CAR T-cell therapy . The results from the first clinical trials have been published in The Lancet, showcasing a remarkable success rate. This therapy is a game changer for patients with blood cancers. It offers hope to those who have exhausted other treatment options. What is CAR T-Cell Therapy? CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an innovative treatment that harnesses the body’s immune system. It trains T-cells to target and destroy cancer cells. This therapy is specifically designed for certain blood cancers. It is particularly beneficial for patients whose cancer has relapsed or failed to respond to standard treatments. Clinical Trial The clinical trials reported a response rate of nearly 73%. This indicates that number of patients benefited from the treatment. The trials also provided critical data on survival rates for patients with acute lymphoblastic leukaemia and l...
Read more

What is Zolgensma?

Image
  Spinal Muscular Atrophy (SMA) is a rare genetic disease affecting muscle function. In India, treatment options are limited, mainly due to high costs. The gene therapy drug, Zolgensma , costs around 16 crore rupees. Despite this, some families are finding ways to access treatment. About Spinal Muscular Atrophy (SMA) SMA is a genetic disorder that leads to the loss of motor neurons in the spinal cord. This results in muscle weakness and atrophy. Symptoms often appear in infancy. Children may struggle with basic movements like lifting their heads or crawling. Early diagnosis is crucial for effective treatment. About Zolgensma Zolgensma (onasemnogene abeparvovec-xioi) is a revolutionary gene therapy for SMA. It addresses the root cause by replacing the missing or defective SMN1 gene . This therapy can improve motor function in affected children. Although it is costly, it represents hope for many families. SMA is not as rare as once thought. The global prevalence is estimated at 1 in ...
Read more